Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: A single-center retrospective study

March 2025 in “Clinical and Experimental Dermatology”

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

$Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib$

research Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib

6 citations , April 2021 in “Frontiers in Immunology”

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

research Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?

60 citations , May 2015 in “Archives of dermatological research”

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer

research A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer

January 2025 in “Recent Patents on Anti-Cancer Drug Discovery”

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

research Immunomodulatory Potential of a Bibenzyl-dihydrophenanthrene Derivative Isolated from Calanthe cardioglossa

3 citations , January 2025 in “Journal of Natural Products”

Calancardin B may help reduce inflammation in immune cells.

research USE OF A HOMEOPATHIC PRODUCT IN DOGS REDUCES THE NEGATIVE EFFECTS OF CANINE ATOPIC DERMATITIS

March 2022 in “Archives of Veterinary Science”

A homeopathic product reduces skin issues and stress in dogs with dermatitis.

research 41824 Palmoplantar psoriasis complete clearance is achieved rapidly and sustained with ixekizumab treatment in adult and pediatric patients with moderate-to-severe plaque psoriasis

2 citations , September 2023 in “Journal of the American Academy of Dermatology”

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

research Oral dutasteride can be considered a first‐line treatment for frontal fibrosing alopecia until high‐quality clinical trials could show better results with other therapies

February 2025 in “Journal of the European Academy of Dermatology and Venereology”

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

research Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study

1 citations , September 2024 in “Frontiers in Pharmacology”

In this real-world study involving 33 advanced non-small cell lung cancer (NSCLC) patients, aumolertinib demonstrated a disease control rate of 91.3% and an objective response rate of 65.2%, aligning with results from the AENEAS trial. Over a median follow-up of 264 days, patient-reported outcomes (PROs) improved significantly, with reductions in symptoms such as cough, sore mouth or tongue, tingling in hands or feet, and various pain sites after 6 months of treatment. These findings suggest that aumolertinib not only effectively controls disease progression but also enhances quality of life, supporting its use as a first-line therapy for NSCLC patients with EGFR-sensitizing mutations.

research Combination cryotherapy and intralesional corticosteroid versus steroid monotherapy in the treatment of keloids

9 citations , November 2022 in “Journal of Cosmetic Dermatology”

Combining cryotherapy with steroids reduces keloid size more effectively than steroids alone.

← Previous page